ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Burden of Clostridioides difficile infection in China, 1990-2021: an analysis based on the global burden of disease study 2021.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNational evidence on the long-term burden of Clostridioides difficile infection (CDI) in China remains limited. We assessed CDI-related burden from 1990 to 2021 and projected rates to 2030.
methodsChina-specific estimates of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) were obtained from the Global Burden of Disease Study 2021 (GBD 2021). Temporal trends were evaluated using joinpoint regression, decomposition analysis, and autoregressive integrated moving average models.
resultsFrom 1990 to 2021, CDI-related DALYs increased from 6,645.59 to 15,759.24, and GBD-estimated CDI-attributable deaths increased from 215 to 721. YLLs accounted for more than 99% of DALYs within the GBD estimation framework. In 2021, DALY rates were higher in males than females and increased markedly with age. The death rate had the highest average annual percentage change. Population aging contributed 57.1% of the increase in DALYs, exceeding the contributions of population growth and epidemiological change. Historical-trend-based projections suggested that all-age burden rates may continue to rise through 2030; YLD projections require additional caution because of possible residual autocorrelation.
conclusionGBD-estimated CDI-related burden in China increased substantially, and age-specific DALY rates were highest among older adults. These model-based findings support strengthened CDI surveillance, diagnostic capacity, antimicrobial stewardship, infection control, and prevention among high-risk older populations.
Indexed as
Identifiers
42560603What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.